EASL

Liver diseases account for 300,000 deaths in Europe each year. With support from the Innovative Health Initiative, a collaboration of researchers, biotechnology companies and the pharmaceutical industry aim to improve the lives and health of people with hidden liver disease by conducting the larg…

Triggered by the rising burden of liver disease, the Lancet and the European Association for the Study of the Liver (EASL) jointly arranged a Commission to explore the landscape of liver health in Europe. The culmination of this work was a first report published in 2021, which offered ten recomme…

The European Association for the Study of the Liver (EASL), as part of the Healthy Livers, Healthy Lives Coalition held a policy webinar on 31 January 2024. Moderated by Nicola Bedlington and featuring esteemed speakers from around the world, this event focused on steatotic liver disease (SLD) an…

The DECISION project, an EU-funded research initiative, is making significant strides in understanding the complex dynamics of acute decompensation of cirrhosis and its progression to acute-on-chronic liver failure (ACLF). In a recent interview, Prof. Pierre-Emmanuel Rautou, DECISION Project Coor…

Endowed with €12 million, the project is coordinated by Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncology, a professor of Medicine at the University of Barcelona (UB) an ICREA professor. The European Union’s THRIVE project (Tumour host interactions in liver…

It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed away at the age of 93. His remarkable contributions to transplant surgery and immunosuppressant drugs…

Every October, we stand united for #LiverCancerAwarenessMonth, and EASL is proud to support this vital campaign. This month is a significant opportunity to raise awareness, educate, and advocate for liver health on a global scale. It serves as a reminder that by working together, we can make a pr…

EASL mourns the loss of Gustav Paumgartner, a luminary in the field of hepatology and a true visionary. Born on November 23, 1933, Gustav’s contributions to liver research and patient care have left an indelible mark on our community. Gustav’s journey began in Styria, Austria, where he developed …

Why did you apply for the EASL YIs Task Force? As a passionate young researcher in the field of hepatology, I believe that the EASL is the perfect platform to further my professional development and contribute to the advancement of our field.…